Oliver Spandow's most recent trade in Nephros Inc was a trade of 33,241 Common Stock done . Disclosure was reported to the exchange on Jan. 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Nephros Inc | Oliver Spandow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 33,241 | 114,845 (1%) | 0% | 0 | Common Stock | |
Nephros Inc | Oliver Spandow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 7,050 | 7,050 | - | - | Stock Option (Right to Buy) | |
Nephros Inc | Oliver Spandow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 7,323 | 7,323 | - | - | Stock Option (Right to Buy) | |
Nephros Inc | Oliver Spandow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 14,294 | 81,604 (0%) | 0% | 0 | Common Stock | |
Nephros Inc | Oliver Spandow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 42,481 | 67,310 (0%) | 0% | 0 | Common Stock | |
Nephros Inc | Oliver Spandow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 7,080 | 7,080 | - | - | Stock Option (Right to Buy) | |
Nephros Inc | Oliver Spandow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 7,062 | 7,062 | - | - | Stock Option (Right to Buy) | |
Nephros Inc | Oliver Spandow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 5,429 | 24,829 (0%) | 0% | 0 | Common Stock | |
Nephros Inc | Oliver Spandow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 6,850 | 6,850 | - | - | Stock Option (Right to Buy) | |
Nephros Inc | Oliver Spandow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 3,666 | 19,400 (0%) | 0% | 0 | Common Stock | |
Nephros Inc | Oliver Spandow | Director | Purchase of securities on an exchange or from another person at price $ 5.83 per share. | 18 Nov 2020 | 1,500 | 15,734 (0%) | 0% | 5.8 | 8,749 | Common Stock |